Hurry Up And Approve: EMA Brings Vaccine Decision Forward After Political Pressure
German Health Minister Speaks Out
Resurgence of the coronavirus across Europe made the approval of Pfizer/BioNTech vaccine and the start of immunization programs more urgent.
You may also be interested in...
Among the 13 new drug marketing applications that the European Medicines Agency has most recently accepted for review are two products that could become the first approved treatments for children with progressive familial intrahepatic cholestasis, a life-threatening disorder.
European parliamentarians have defended the formal marketing authorization approach being taken by the EU, saying “safety is of the utmost importance” if there is to be trust in coronavirus vaccines.
Moderna’s COVID-19 vaccine looks better than Pfizer/BioNTech’s at preventing severe disease and like it may offer some benefit in preventing asymptomatic infections, but these advantages may be short-lived and hard to capitalize on due to supply limitations.